![FDA Crisis for Pfizer: The Impact of an FDA Warning On the Company – Cases and Tools in Biotechnology Management FDA Crisis for Pfizer: The Impact of an FDA Warning On the Company – Cases and Tools in Biotechnology Management](https://ecampusontario.pressbooks.pub/app/uploads/sites/73/2019/04/JAK-pathway.jpg)
FDA Crisis for Pfizer: The Impact of an FDA Warning On the Company – Cases and Tools in Biotechnology Management
![Pfizer Xeljanz, Tofacitinib (tofacitinib citrate), JAK inhibitor, 11mg tablets, once daily treatment in sustained release tablet form, France Stock Photo - Alamy Pfizer Xeljanz, Tofacitinib (tofacitinib citrate), JAK inhibitor, 11mg tablets, once daily treatment in sustained release tablet form, France Stock Photo - Alamy](https://c8.alamy.com/comp/2FMCWHR/pfizer-xeljanz-tofacitinib-tofacitinib-citrate-jak-inhibitor-11mg-tablets-once-daily-treatment-in-sustained-release-tablet-form-france-2FMCWHR.jpg)
Pfizer Xeljanz, Tofacitinib (tofacitinib citrate), JAK inhibitor, 11mg tablets, once daily treatment in sustained release tablet form, France Stock Photo - Alamy
![Molecules | Free Full-Text | Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates Molecules | Free Full-Text | Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates](https://www.mdpi.com/molecules/molecules-25-03321/article_deploy/html/images/molecules-25-03321-g001.png)
Molecules | Free Full-Text | Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates
![Pharmas with up-and-coming JAK inhibitors face 'shrinking' potential after FDA crackdown | Fierce Biotech Pharmas with up-and-coming JAK inhibitors face 'shrinking' potential after FDA crackdown | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1630593902/GettyImages-1211291206.jpg/GettyImages-1211291206.jpg?VersionId=aoWHt887p6x2TMZZdnvq45gfI.vadaLx)
Pharmas with up-and-coming JAK inhibitors face 'shrinking' potential after FDA crackdown | Fierce Biotech
![The EU CHMP recommends approval of Pfizer's 2 JAK inhibitors Cibinqo (abxitinib) and Xeljanz (tofacitinib)! - Knowledge - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd The EU CHMP recommends approval of Pfizer's 2 JAK inhibitors Cibinqo (abxitinib) and Xeljanz (tofacitinib)! - Knowledge - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd](https://www.hsppharma.com/Content/uploads/2021524038/202111041625269740dbb43015449f9b870c64b8281029.png)
The EU CHMP recommends approval of Pfizer's 2 JAK inhibitors Cibinqo (abxitinib) and Xeljanz (tofacitinib)! - Knowledge - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd
![Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis | Business Wire Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis | Business Wire](https://mms.businesswire.com/media/20160224006053/en/511097/5/2486042_XELJANZ_XR_LOGO_cmyk_lock_up+%281%29.jpg)
Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis | Business Wire
![JAK inhibitors from Pfizer, AbbVie and Lilly hit with dreaded FDA heart safety, cancer warnings | Fierce Pharma JAK inhibitors from Pfizer, AbbVie and Lilly hit with dreaded FDA heart safety, cancer warnings | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1630512971/5204602349_c87b204860_b.jpg/5204602349_c87b204860_b.jpg?VersionId=ra49dVkifjcfMO4tA2udoNux6GKHxqDh)